市場調査レポート

商品コード

1762435

ファブリー病治療市場、規模、シェア、産業分析レポート：投与経路別、治療別、流通チャネル別、地域別、2025年～2034年の市場予測

Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034

出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 630,997円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 779,467円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 927,937円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、ファブリー病治療市場規模は2034年までに53億2,112万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ファブリー病治療市場は、a-ガラクトシダーゼA酵素の欠損によって引き起こされる稀なX連鎖性リソソーム貯蔵障害であるファブリー病の臨床症状を管理するように設計された治療法の開発と商業化に焦点を当てています。この酵素欠損はグロボトリアオシルセラミド（Gb3）の全身蓄積を引き起こし、腎臓、心臓、神経系などの重要臓器に進行性の障害をもたらします。この市場は、標的酵素補充療法（ERT）の進歩や、ミスフォールドした酵素を安定化させることを目的とした経口シャペロン療法の利用可能性の拡大によって推進されています。ヘルスケア提供者の意識の高まりと診断能力の向上が早期発見に寄与し、治療対象者を拡大しています。希少疾病研究への戦略的投資は、希少疾病治療薬の開発や精密医療プラットフォームなど、技術革新を促進し、規制当局の承認を加速させています。市場参入企業は、次世代治療法への重要な動向を反映し、耐久性または治癒の可能性を提供する遺伝子治療パイプラインへの注力を強めています。

保険償還の枠組みの改善や、バイオ医薬品企業と学術機関との共同研究イニシアチブは、差別化された治療ソリューション開発の新たな機会を生み出しています。また、多様な患者サブグループにおけるアンメットニーズに対応するため、遅発型や非定型の表現型に合わせた治療法の開発が重視されるようになってきています。市販後調査や実臨床でのエビデンス作成を通じて長期的な有効性と安全性をモニタリングする取り組みが強化され、治療法の選択に対する信頼性が高まっています。全体として、市場は、アンメットニーズの高さ、臨床の複雑さ、生物学的製剤と低分子製剤の両方における革新への力強い推進力を特徴とするダイナミックな状況を反映しています。

ファブリー病治療市場レポート・ハイライト

投与経路別では、2024年に静脈内投与が最大シェアを占めました。静脈内投与は、ファブリー病治療における酵素補充療法（ERT）の主要な投与方法です。

治療に基づくと、2024年には酵素補充療法（ERT）セグメントがシェアの約60％を占めました。ERTは、アガルシダーゼ・アルファやベータなどの合成酵素を静脈内に注入するもので、Gb3の分解を助け、病気の進行を遅らせ、神経障害性疼痛、胃腸障害、臓器機能障害などの症状を緩和します。

2024年、アジア太平洋地域のファブリー病治療市場は、希少遺伝子疾患に対する認識の高まりと、同地域における診断インフラの拡充により、最大のシェアを占めています。

ラテンアメリカのファブリー病治療市場は、2025年から2034年にかけて大きく成長すると予測されています。ラテンアメリカのヘルスケアプロバイダー、政府、支援団体は、早期診断と治療法へのアクセスを優先しており、地域市場の拡大に拍車をかけています。

世界の主要企業としては、Amicus Therapeutics, Inc.、CANbridge Life Sciences Ltd.、Chiesi Farmaceutici S.p.A.、Idorsia Pharmaceuticals Ltd.、ISU ABXIS Co., Ltd.、JCR Pharmaceuticals Co., Ltd.、Protalix Biotherapeutics Inc.、Sangamo Therapeutics, Inc.、サノフィ、武田薬品工業などが挙げられます。

市場スナップショット
ファブリー病治療市場力学
- 促進要因と機会
  - ファブリー病治療における個別化医療の導入
  - 償還ポリシーの拡大
- 抑制要因と課題
  - 熟練した人材の不足
PESTEL分析
ファブリー病治療市場の動向
バリューチェーン分析

第5章世界のファブリー病治療市場：投与経路別

主な調査結果
イントロダクション
静脈内投与
経口経路

第6章世界のファブリー病治療市場：治療別

主な調査結果
イントロダクション
酵素補充療法（ERT）
基質還元療法（SRT）
その他

第7章世界のファブリー病治療市場：流通チャネル別

主な調査結果
イントロダクション
病院薬局
小売薬局
オンライン薬局

第8章世界のファブリー病治療市場：地域別

主な調査結果
イントロダクション
- ファブリー病治療市場評価：地域、2020年～2034年
北米
- 北米：投与経路別、2020～2034年
- 北米：治療別、2020～2034年
- 北米：流通チャネル別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：投与経路別、2020～2034年
- 欧州：治療別、2020～2034年
- 欧州：流通チャネル別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋地域：投与経路別、2020～2034年
- アジア太平洋地域：治療別、2020～2034年
- アジア太平洋地域：流通チャネル別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ
- 中東・アフリカ：投与経路別、2020～2034年
- 中東・アフリカ：治療別、2020～2034年
- 中東・アフリカ：流通チャネル別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
ラテンアメリカ
- ラテンアメリカ：投与経路別、2020～2034年
- ラテンアメリカ：治療別、2020～2034年
- ラテンアメリカ：流通チャネル別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Amicus Therapeutics, Inc.
CANbridge Life Sciences Ltd.
Chiesi Farmaceutici S.p.A.
Idorsia Pharmaceuticals Ltd.
ISU ABXIS Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
Protalix Biotherapeutics Inc.
Sangamo Therapeutics, Inc.
Sanofi
Takeda Pharmaceutical

図表

List of Tables:

Table 1 Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 2 Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 3 Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 4 North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 5 North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 6 North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 7 U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 8 U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 9 U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 10 Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 11 Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 12 Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 13 Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 14 Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 15 Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 16 UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 17 UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 18 UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 19 France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 20 France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 21 France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 22 Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 23 Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 24 Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 25 Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 26 Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 27 Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 28 Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 29 Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 30 Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 31 Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 32 Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 33 Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 34 Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 35 Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 36 Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 37 Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 38 Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 39 Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 40 Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 41 Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 42 Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 43 China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 44 China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 45 China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 46 India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 47 India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 48 India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 49 Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 50 Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 51 Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 52 Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 53 Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 54 Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 55 Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 56 Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 57 Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 58 South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 59 South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 60 South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 61 Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 62 Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 63 Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 64 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 65 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 66 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 67 Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 68 Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 69 Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 70 Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 71 Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 72 Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 73 UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 74 UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 75 UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 76 Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 77 Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 78 Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 79 South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 80 South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 81 South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 82 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 83 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 84 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 85 Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 86 Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 87 Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 88 Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 89 Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 90 Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 91 Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 92 Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 93 Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 94 Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 95 Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 96 Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
Table 97 Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
Table 98 Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
Table 99 Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Fabry's Disease Treatment Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Route of Administration
Figure 7. Global Fabry's Disease Treatment Market, by Route of Administration, 2024 & 2034 (USD Million)
Figure 8. Market by Therapy
Figure 9. Global Fabry's Disease Treatment Market, by Therapy, 2024 & 2034 (USD Million)
Figure 10. Market by Distribution Channel
Figure 11. Global Fabry's Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Million)

Product Code: PM5760

The fabry's disease treatment market size is expected to reach USD 5,321.12 million by 2034, according to a new study by Polaris Market Research. The report "Fabry's Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Fabry's disease treatment market focuses on the development and commercialization of therapies designed to manage the clinical manifestations of Fabry disease, a rare X-linked lysosomal storage disorder caused by a deficiency of the a-galactosidase A enzyme. This enzymatic deficit leads to the systemic accumulation of globotriaosylceramide (Gb3), resulting in progressive damage to vital organs such as the kidneys, heart, and nervous system. The market is being propelled by advances in targeted enzyme replacement therapy (ERT) and the growing availability of oral chaperone therapies that aim to stabilize the misfolded enzymes. Rising awareness among healthcare providers and improved diagnostic capabilities are contributing to earlier detection, expanding the eligible treatment population. Strategic investments in rare disease research, including orphan drug development and precision medicine platforms, are fostering innovation and accelerating regulatory approvals. Market participants are increasingly focusing on gene therapy pipelines that offer the potential for durable or curative outcomes, reflecting a key trend toward next-generation modalities.

Improved reimbursement frameworks and collaborative research initiatives between biopharmaceutical companies and academic institutions are creating new opportunities for the development of differentiated treatment solutions. There is also a rising emphasis on developing treatments tailored to late-onset and atypical phenotypes, addressing unmet needs in diverse patient subgroups. Increasing efforts to monitor long-term efficacy and safety through post-marketing surveillance and real-world evidence generation are reinforcing confidence in therapeutic choices. Overall, the market reflects a dynamic landscape marked by high unmet need, significant clinical complexity, and a robust drive toward innovation in both biologic and small-molecule therapies.

Fabry's Disease Treatment Market Report Highlights

By route of administration, in 2024, the intravenous route segment accounted for the largest share. Intravenous (IV) administration is the primary method for delivering enzyme replacement therapy (ERT) in Fabry disease treatment.

Based on therapy, in 2024, the enzyme replacement therapy (ERT) segment accounted for approximately 60% of the share. ERT involves intravenous infusions of synthetic enzymes such as agalsidase alfa or beta, which help break down Gb3, slowing disease progression and alleviating symptoms such as neuropathic pain, gastrointestinal issues, and organ dysfunction.

In 2024, the Asia Pacific Fabry's disease treatment market accounted for the largest share due to increasing awareness of rare genetic disorders and the expansion of diagnostic infrastructure in the region.

The Latin America Fabry's disease treatment market is projected to grow significantly from 2025 to 2034. Healthcare providers, governments, and advocacy groups in LATAM are prioritizing early diagnosis and access to therapies, fueling the regional market expansion.

A few global key players include Amicus Therapeutics, Inc.; CANbridge Life Sciences Ltd.; Chiesi Farmaceutici S.p.A.; Idorsia Pharmaceuticals Ltd.; ISU ABXIS Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; Protalix Biotherapeutics Inc.; Sangamo Therapeutics, Inc.; Sanofi; and Takeda Pharmaceutical.

Polaris Market Research has segmented the Fabry's disease treatment market report on the basis of route of administration, therapy, distribution channel, and region:

By Route of Administration Outlook (Revenue, USD Million, 2020-2034)

Intravenous Route

Oral Route

By Therapy Outlook (Revenue, USD Million, 2020-2034)

Enzyme Replacement Therapy (ERT)

Substrate Reduction Therapy (SRT)

Others

By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Fabry's Disease Treatment Market Insights

4.1. Fabry's Disease Treatment Market - Market Snapshot
4.2. Fabry's Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Personalized Medicine Adoption in Fabry Disease Care
  - 4.2.1.2. Expansion of Reimbursement Policies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Shortage of Skilled Personal
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Fabry's Disease Treatment Market Trends
4.6. Value Chain Analysis

5. Global Fabry's Disease Treatment Market, by Route of Administration

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
5.3. Intravenous Route
- 5.3.1. Global Fabry's Disease Treatment Market, by Intravenous Route, by Region, 2020-2034 (USD Million)
5.4. Oral Route
- 5.4.1. Global Fabry's Disease Treatment Market, by Oral Route, by Region, 2020-2034 (USD Million)

6. Global Fabry's Disease Treatment Market, by Therapy

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
6.3. Enzyme Replacement Therapy (ERT)
- 6.3.1. Global Fabry's Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Million)
6.4. Substrate Reduction Therapy (SRT)
- 6.4.1. Global Fabry's Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Fabry's Disease Treatment Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Fabry's Disease Treatment Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
7.3. Hospital Pharmacies
- 7.3.1. Global Fabry's Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Million)
7.4. Retail Pharmacies
- 7.4.1. Global Fabry's Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
7.5. Online Pharmacies
- 7.5.1. Global Fabry's Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Fabry's Disease Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Fabry's Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Fabry's Disease Treatment Market - North America
- 8.3.1. North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
- 8.3.2. North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
- 8.3.3. North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.4. Fabry's Disease Treatment Market - U.S.
  - 8.3.4.1. U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.5. Fabry's Disease Treatment Market - Canada
  - 8.3.5.1. Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
8.4. Fabry's Disease Treatment Market - Europe
- 8.4.1. Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.2. Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
- 8.4.3. Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.4. Fabry's Disease Treatment Market - UK
  - 8.4.4.1. UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.5. Fabry's Disease Treatment Market - France
  - 8.4.5.1. France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.5.2. France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.5.3. France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.6. Fabry's Disease Treatment Market - Germany
  - 8.4.6.1. Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.7. Fabry's Disease Treatment Market - Italy
  - 8.4.7.1. Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.8. Fabry's Disease Treatment Market - Spain
  - 8.4.8.1. Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.9. Fabry's Disease Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.10. Fabry's Disease Treatment Market - Russia
  - 8.4.10.1. Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.11. Fabry's Disease Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
8.5. Fabry's Disease Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.4. Fabry's Disease Treatment Market - China
  - 8.5.4.1. China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.4.2. China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.4.3. China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.5. Fabry's Disease Treatment Market - India
  - 8.5.5.1. India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.5.2. India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.5.3. India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.6. Fabry's Disease Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.7. Fabry's Disease Treatment Market - Japan
  - 8.5.7.1. Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.8. Fabry's Disease Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.9. Fabry's Disease Treatment Market - South Korea
  - 8.5.9.1. South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.10. Fabry's Disease Treatment Market - Australia
  - 8.5.10.1. Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.11. Fabry's Disease Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
8.6. Fabry's Disease Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.4. Fabry's Disease Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.5. Fabry's Disease Treatment Market - UAE
  - 8.6.5.1. UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.6. Fabry's Disease Treatment Market - Israel
  - 8.6.6.1. Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.7. Fabry's Disease Treatment Market - South Africa
  - 8.6.7.1. South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.8. Fabry's Disease Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
8.7. Fabry's Disease Treatment Market - Latin America
- 8.7.1. Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.2. Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
- 8.7.3. Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.4. Fabry's Disease Treatment Market - Mexico
  - 8.7.4.1. Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.5. Fabry's Disease Treatment Market - Brazil
  - 8.7.5.1. Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.6. Fabry's Disease Treatment Market - Argentina
  - 8.7.6.1. Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.7. Fabry's Disease Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amicus Therapeutics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. CANbridge Life Sciences Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Chiesi Farmaceutici S.p.A.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Idorsia Pharmaceuticals Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. ISU ABXIS Co., Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. JCR Pharmaceuticals Co., Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Protalix Biotherapeutics Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Sangamo Therapeutics, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Sanofi
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Takeda Pharmaceutical
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

ファブリー病治療市場、規模、シェア、産業分析レポート：投与経路別、治療別、流通チャネル別、地域別、2025年～2034年の市場予測

Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034

ファブリー病治療市場レポート・ハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のファブリー病治療市場の洞察

第5章世界のファブリー病治療市場：投与経路別

第6章世界のファブリー病治療市場：治療別

第7章世界のファブリー病治療市場：流通チャネル別

第8章世界のファブリー病治療市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Fabry's Disease Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Fabry's Disease Treatment Market Insights

5. Global Fabry's Disease Treatment Market, by Route of Administration

6. Global Fabry's Disease Treatment Market, by Therapy

7. Global Fabry's Disease Treatment Market, by Distribution Channel

8. Global Fabry's Disease Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

ファブリー病治療市場、規模、シェア、産業分析レポート：投与経路別、治療別、流通チャネル別、地域別、2025年～2034年の市場予測

Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034

ファブリー病治療市場レポート・ハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のファブリー病治療市場の洞察

第5章 世界のファブリー病治療市場：投与経路別

第6章 世界のファブリー病治療市場：治療別

第7章 世界のファブリー病治療市場：流通チャネル別

第8章 世界のファブリー病治療市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Fabry's Disease Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Fabry's Disease Treatment Market Insights

5. Global Fabry's Disease Treatment Market, by Route of Administration

6. Global Fabry's Disease Treatment Market, by Therapy

7. Global Fabry's Disease Treatment Market, by Distribution Channel

8. Global Fabry's Disease Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のファブリー病治療市場の洞察

第5章世界のファブリー病治療市場：投与経路別

第6章世界のファブリー病治療市場：治療別

第7章世界のファブリー病治療市場：流通チャネル別

第8章世界のファブリー病治療市場：地域別

第9章競合情勢

第10章企業プロファイル